• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

山奈酚诱导细胞死亡并增强人头颈鳞状细胞癌细胞系对顺铂的敏感性。

Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin.

机构信息

Clinical and Molecular Pharmacology Program, Institute of Biomedical Sciences (ICBM), Faculty of Medicine, Universidad de Chile, Santiago, Chile.

Institute for Research in Dental Sciences (ICOD), Faculty of Dentistry, Universidad de Chile, Santiago, Chile.

出版信息

Adv Exp Med Biol. 2021;1326:95-109. doi: 10.1007/5584_2020_603.

DOI:10.1007/5584_2020_603
PMID:33368015
Abstract

Cisplatin is a first-line chemotherapeutic drug commonly used to treat patients with head and neck cancer; nevertheless, cisplatin resistance poses a main challenge for its clinical efficacy. Recent studies have shown that kaempferol, a natural flavonoid found in various plants and foods, has an anticancer effect. The following study evaluated the cytotoxic effects of kaempferol on head and neck tumor cells and their mechanism of action, evaluating the effects on proliferation, the oxygen consumption rate, transmembrane potential, tumor cell migration and induction of apoptosis. Moreover, we determined the effects of a combination of kaempferol and cisplatin on head and neck tumor cells. We found that kaempferol inhibited the oxygen consumption rate and decreased the intracellular ATP content in tumor cells. This novel mechanism may inhibit the migratory capacity and promote antiproliferative effects and apoptosis of tumor cells. Additionally, our in vitro data indicated that kaempferol may sensitize head and neck tumor cells to the effects of cisplatin. These effects provide new evidence for the use of a combination of kaempferol and cisplatin in vivo and their future applications in head and neck cancer therapy.

摘要

顺铂是一种常用的一线化疗药物,用于治疗头颈部癌症患者;然而,顺铂耐药性是其临床疗效的主要挑战。最近的研究表明,山奈酚是一种存在于多种植物和食物中的天然类黄酮,具有抗癌作用。本研究评估了山奈酚对头颈部肿瘤细胞的细胞毒性作用及其作用机制,评估了对增殖、耗氧量、跨膜电位、肿瘤细胞迁移和诱导细胞凋亡的影响。此外,我们还确定了山奈酚与顺铂联合应用对头颈部肿瘤细胞的影响。我们发现山奈酚抑制了肿瘤细胞的耗氧量并降低了细胞内 ATP 含量。这种新的机制可能抑制了肿瘤细胞的迁移能力,促进了增殖抑制和细胞凋亡。此外,我们的体外数据表明,山奈酚可能使头颈部肿瘤细胞对顺铂的作用敏感。这些作用为体内联合使用山奈酚和顺铂提供了新的证据,并为其在头颈部癌症治疗中的未来应用提供了依据。

相似文献

1
Kaempferol Induces Cell Death and Sensitizes Human Head and Neck Squamous Cell Carcinoma Cell Lines to Cisplatin.山奈酚诱导细胞死亡并增强人头颈鳞状细胞癌细胞系对顺铂的敏感性。
Adv Exp Med Biol. 2021;1326:95-109. doi: 10.1007/5584_2020_603.
2
VE-822 Enhanced Cisplatin Chemotherapy Effects on Head and Neck Squamous Cell Carcinoma Drug-resistant Cells.VE-822 增强顺铂化疗对头颈部鳞状细胞癌耐药细胞的作用。
Curr Cancer Drug Targets. 2023;23(6):482-495. doi: 10.2174/1568009623666230206143216.
3
Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma.姜烯酮可作为头颈部鳞状细胞癌的放射增敏剂。
Invest New Drugs. 2022 Apr;40(2):224-231. doi: 10.1007/s10637-021-01190-7. Epub 2021 Oct 6.
4
IN VITRO ANTICANCER ACTIVITY OF HISTATIN-1 COMBINATION WITH CISPLATIN IN HEAD AND NECK CANCER CELL LINES.组蛋白结合顺铂对头颈部癌细胞系的体外抗癌活性。
Exp Oncol. 2024 Oct 9;46(2):101-109. doi: 10.15407/exp-oncology.2024.02.101.
5
Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.醛脱氢酶1 A1抑制可消除头颈部癌中癌症干细胞介导的获得性化疗耐药性。
Mol Carcinog. 2017 Feb;56(2):694-711. doi: 10.1002/mc.22526. Epub 2016 Aug 4.
6
Combined treatment with acetazolamide and cisplatin enhances the chemosensitivity of human head and neck squamous cell carcinoma TU868 cells.乙酰唑胺和顺铂联合治疗增强人头颈鳞癌细胞 TU868 的化疗敏感性。
Arch Oral Biol. 2020 Nov;119:104905. doi: 10.1016/j.archoralbio.2020.104905. Epub 2020 Sep 9.
7
HS-173, a selective PI3K inhibitor, induces cell death in head and neck squamous cell carcinoma cell lines.HS-173,一种选择性的 PI3K 抑制剂,可诱导头颈部鳞状细胞癌细胞系发生细胞死亡。
Wien Klin Wochenschr. 2021 Jan;133(1-2):26-31. doi: 10.1007/s00508-020-01729-3. Epub 2020 Sep 2.
8
Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.表观遗传修饰控制头颈部鳞状细胞癌固有顺铂耐药性来源的癌症干细胞丧失黏附和侵袭能力。
Arch Oral Biol. 2022 Sep;141:105468. doi: 10.1016/j.archoralbio.2022.105468. Epub 2022 Jun 1.
9
p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.p90RSK通路抑制与顺铂在过表达TMEM16A的头颈癌中具有协同作用。
BMC Cancer. 2024 Feb 19;24(1):233. doi: 10.1186/s12885-024-11892-9.
10
Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways.姜黄素与一种抗肿瘤药物对头颈鳞状细胞癌的联合作用:通过调控表皮生长因子受体-细胞外信号调节激酶1/2(EGFR-ERK1/2)和凋亡信号通路
ACS Comb Sci. 2016 Jan 11;18(1):22-35. doi: 10.1021/acscombsci.5b00043. Epub 2015 Nov 18.

引用本文的文献

1
The Anticancer Potential of Kaempferol: A Systematic Review Based on In Vitro Studies.山奈酚的抗癌潜力:基于体外研究的系统综述
Cancers (Basel). 2024 Jan 30;16(3):585. doi: 10.3390/cancers16030585.
2
Effects and Mechanisms of Kaempferol in the Management of Cancers through Modulation of Inflammation and Signal Transduction Pathways.山奈酚通过调控炎症和信号转导通路在癌症管理中的作用及机制。
Int J Mol Sci. 2023 May 11;24(10):8630. doi: 10.3390/ijms24108630.
3
Exploring the Remarkable Chemotherapeutic Potential of Polyphenolic Antioxidants in Battling Various Forms of Cancer.

本文引用的文献

1
Quercetin and cancer: new insights into its therapeutic effects on ovarian cancer cells.槲皮素与癌症:对其治疗卵巢癌细胞效果的新见解。
Cell Biosci. 2020 Mar 10;10:32. doi: 10.1186/s13578-020-00397-0. eCollection 2020.
2
Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review.头颈部癌症预后的新型临床因素和生物标志物:系统评价。
Lancet Oncol. 2019 Jun;20(6):e313-e326. doi: 10.1016/S1470-2045(19)30177-9.
3
Regulation of cisplatin-resistant head and neck squamous cell carcinoma by the SRC/ETS-1 signaling pathway.
探讨多酚类抗氧化剂在对抗多种形式癌症中的显著化疗潜力。
Molecules. 2023 Apr 14;28(8):3475. doi: 10.3390/molecules28083475.
4
A systematic review of anti-cancer roles and mechanisms of kaempferol as a natural compound.对天然化合物山奈酚的抗癌作用及机制的系统评价。
Cancer Cell Int. 2022 Aug 20;22(1):260. doi: 10.1186/s12935-022-02673-0.
SRC/ETS-1 信号通路调控顺铂耐药的头颈部鳞状细胞癌。
BMC Cancer. 2019 May 22;19(1):485. doi: 10.1186/s12885-019-5664-7.
4
Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review.复发性或转移性头颈部癌的靶向治疗:最新进展和新视角。系统评价。
Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.
5
Phytochemicals: Current strategy to sensitize cancer cells to cisplatin.植物化学物质:使癌细胞对顺铂敏感的当前策略。
Biomed Pharmacother. 2019 Feb;110:518-527. doi: 10.1016/j.biopha.2018.12.010. Epub 2018 Dec 7.
6
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.桑色素降低半乳糖凝集素-3的表达并使卵巢癌细胞对顺铂敏感。
Arch Gynecol Obstet. 2018 Dec;298(6):1181-1194. doi: 10.1007/s00404-018-4912-4. Epub 2018 Sep 28.
7
RETRACTED: Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microRNA-340 in human lung cancer cells.撤稿:山奈酚通过上调人肺癌细胞 microRNA-340 抑制增殖但增加凋亡和自噬。
Biomed Pharmacother. 2018 Dec;108:809-816. doi: 10.1016/j.biopha.2018.09.087. Epub 2018 Sep 22.
8
Antitumor, antioxidant and anti-inflammatory activities of kaempferol and its corresponding glycosides and the enzymatic preparation of kaempferol.山柰酚及其糖苷的抗肿瘤、抗氧化和抗炎活性及山柰酚的酶法制备。
PLoS One. 2018 May 17;13(5):e0197563. doi: 10.1371/journal.pone.0197563. eCollection 2018.
9
Cisplatin-induced gastrointestinal toxicity: An update on possible mechanisms and on available gastroprotective strategies.顺铂诱导的胃肠道毒性:可能机制及现有胃保护策略的更新。
Eur J Pharmacol. 2018 May 15;827:49-57. doi: 10.1016/j.ejphar.2018.03.009. Epub 2018 Mar 9.
10
KAEMPFEROL, A FLAVONOID COMPOUND FROM INDUCED APOPTOSIS AND GROWTH INHIBITION IN MCF-7 BREAST CANCER CELL.山奈酚,一种来自诱导MCF-7乳腺癌细胞凋亡和生长抑制的黄酮类化合物。
Afr J Tradit Complement Altern Med. 2016 Jul 3;13(4):210-215. doi: 10.21010/ajtcam.v13i4.27. eCollection 2016.